Back to TCRX

UBS Group AG → TCRX

UBS Group AG TCRX Position History

TScan Therapeutics, Inc. • Healthcare

Quarters held
10
Latest value
$34K
Q3 2026
Peak value
$55K
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$18K
Q3 2025$2K
Q4 2025$55K
Q4 2025$58
Q1 2026$7K
Q1 2026$25K
Q2 2026$54K
Q2 2026$27
Q2 2026$13K
Q3 2026$34K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$34K108.2K——
Q2 2026$13K13.6K——
Q2 2026$2728——
Q2 2026$54K55.3K——
Q1 2026$25K25.1K——
Q1 2026$7K7.4K——
Q4 2025$5858——
Q4 2025$55K55.1K——
Q3 2025$2K1.3K——
Q3 2025$18K9.7K——

Other funds holding TCRX

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B